Question: If Zandopa, the product some of us buy direct from India is involved in clinical trails will that affect our ability to get this product? With this agreement with CMI to finance (to the tune of $10 million) clinical and pharmaceutical development to obtain drug marketing approval not suggest a large price increase to the consumer. Like some have said on this forum, we could see this coming.............Would that be in the foiled again category!